Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amylx
Amylx
Amylyx Purchases Investigational GLP-1 Drug Avexitide in Auction Deal for $35 Million
Xtalks
Mon, 07/15/24 - 11:27 pm
Amylx
GLP-1 agonist
Eiger BioPharmaceuticals
avexitide
5 Neuro Data Readouts to Watch in the Second Half of 2024
BioSpace
Mon, 07/15/24 - 11:43 am
neurology
clinical trials
Athira Pharma
fosgonimeton
Alzheimer's disease
AbbVie
Cerevel Therapeutics
emraclidine
schizophrenia
Neumora Therapeutics
major depressive disorder
navacaprant
Amylx
AMX003
Wolfram syndrome
Vigil Neuroscience
iluzanebart
10 clinical trials to watch in the first half of 2024
BioPharma Dive
Wed, 01/3/24 - 05:08 pm
clinical trials
Beam Therapeutics
Moderna Therapeutics
Pfizer
Sanofi
Gilead Sciences
JNJ
Amylx
Roche
Alnylam Pharmaceuticals
Vertex Pharmaceuticals
Amylyx ALS drug sales tick higher after fast US launch
BioPharma Dive
Mon, 08/14/23 - 10:22 am
Amylx
earnings
ALS
Amylyx Augments Case for ALS Drug Ahead of PDUFA Date
BioSpace
Thu, 05/5/22 - 11:30 pm
Amylx
AMX0035
ALS
FDA
Go or no go? Bristol’s Lag3 debut
EP Vantage
Fri, 02/25/22 - 10:21 am
Bristol Myers Squibb
relatlimab
FDA
AMX0035
Amylx
Biogen leads the amyotrophic lateral sclerosis hopefuls
EP Vantage
Thu, 09/16/21 - 10:41 am
ALS
Amylx
Biogen
Ionis Pharmaceuticals
AB Science
Cytokinetics